GlassScriptPhysician profile
Peter Regala
NPI 1427518711
$26,136.88
in general payments reported to CMS, 2019-2025
8 companies · $25K in 2025
The $25K reported for 2025 was more than what 92% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,425 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $23K · Food and Beverage: $2,435 · Travel and Lodging: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $22,500.00 |
| Food and Beverage | $2,435.24 |
| Travel and Lodging | $1,201.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,821.48 | 2025 | |
| Smith+Nephew, INC. | $3,183.43 | 2024-2025 | Spatial Frame, Bone Anchors With Arthroscopic Delivery System, Novostitch |
| Miach Orthopaedics, INC. | $410.40 | 2025 | |
| Stryker Corporation | $222.04 | 2025 | Gamma |
| Zimmer Biomet Holdings, INC. | $197.66 | 2025 | Comprehensive Shoulder System |
| Nalu Medical, INC. | $168.33 | 2025 | Nalu Neurostimulation System |
| Depuy Synthes Sales INC. | $96.63 | 2025 | Tfn-Advance |
| Solventum Corporation | $36.91 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Regala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.